All Braeburn Sales Reps fired on 1/22/18 !!!

Base for Reps starting at 130k.

 

Nah, I heard it was one fiddy. $$$

 

Titan says they want the rights to probuphine back.

 

That was their starting point in negotiation.

 

Well, Titan is dumb enough to trust Braeburn that's for sure. Bottom line, the REMS and insurance pre-approvals make probuphine impossible to sell. Maybe they'll do better with injectables

 

Y’all mf’ers just sitting here wishing upon a star. You think Indivior is run poorly. They trying to buy relationships with a weak ass product. Gonna make 125 for about 5 months. Lol

 

You’re right. At the moment, we haven’t got anything better to do.

 

Can't wait to outsell Indivior.

 

Good luck with that. They still have the Film, which is going to bring in solid cash flow. You have, what, $110 million from investors? If they haven’t pulled out. Indivior makes that in half a quarter. You’re banking on a product that is already 2nd to the party against a giant. I have no skin in the game, but looking at it from an investor’s point of view, they’re going to be hard to beat. They have the cash flow, history, and relationships you don’t. Every single time a competitor has tried to take them on, they have lost. Look at BDSI and Orexo, they’re barely making it. I hope you succeed, honestly, because more treatment options is good. But don’t get cocky when you aren’t on the market yet, and won’t be for several more months.

 

Good luck with that. They still have the Film, which is going to bring in solid cash flow. You have, what, $110 million from investors? If they haven’t pulled out. Indivior makes that in half a quarter. You’re banking on a product that is already 2nd to the party against a giant. I have no skin in the game, but looking at it from an investor’s point of view, they’re going to be hard to beat. They have the cash flow, history, and relationships you don’t. Every single time a competitor has tried to take them on, they have lost. Look at BDSI and Orexo, they’re barely making it. I hope you succeed, honestly, because more treatment options is good. But don’t get cocky when you aren’t on the market yet, and won’t be for several more months.

 

What she said